InnoVations in MedTechNo Specimen. No Delay

Real-Time Diagnostics at the Point of Care


Breakthrough in Non-Invasive Diagnostics: Real-Time Pathogen & Disease Detection Using AI-Enhanced Spectroscopy

  • Our diagnostic platform eliminates the need for swabs, blood draws, or lab processing. Using a fingertip scan and AI/ML, we deliver actionable results in under 30 seconds – right at the point of care.
  • AI-powered, no-specimen diagnostic platform enables rapid, non-invasive, lab-free detection, providing instant, highly accurate point-of-care results—without the need for biological samples.

·  Read more about our cutting-edge approach to diagnostics.


Our Inventions

No specimen viral detector

No Specimen Diagnostic Device

  • A laser shines on the patient’s fingertip
  • Optical sensors capture unique spectral signatures
  • AI/ML algorithms instantly classify infection status
  • Results are displayed in real time – no lab, no waiting
  • Environmentally friendly
Covid detector

Please Read our Peer-Reviewed Published Manuscript

Visual Display of Negative Test Result
Covid Test Result
Visual Display of Positive Test Result

Validated Clinical Accuracy

  • 455-patient clinical study
  • Achieved AUROC of 0.896 for infection detection
  • Proven consistent performance across ER, ICU, urgent care settings
  • Peer-reviewed publication

Built for Emergency & Urgent Care

  • 30-second turnaround – faster than rapid antigen or PCR
  • Zero specimen handling – ideal for high-volume triage
  • Non-invasive and repeatable – safer for immunocompromised patients

Powered by Optical Engineering + Machine Learning

  • Spectroscopy offers molecular-level precision
  • AI/ML trained on labelled clinical datasets
  • Platform supports future expansion to other disease targets

* Backed by Patients and Patents*

Comments

  • “Your work on integrating artificial intelligence with Raman spectroscopy for diagnostic purposes is indeed innovative. The concept of a device that can be easily recalibrated for different medical applications is promising.”
  • “This will replace blood testing in 10 years.”
  • “The potential here seemed incredibly powerful and could revolutionize noninvasive testing.”
  • “The sky is the limit with this technology”

Pipeline

  • Next-Gen Precision Surgical Cancer Probe
  • Autonomous Infusion Device
Autonomous IV pole

Autonomous Infusion Device

Reduce IV Alarms by Automatically

  • Change low volume bags
  • Flush catheters
  • Unkink tubing
  • Aspirate air bubbles
  • Charge low batteries
Robotic infusion device

Meet the Team

Allen Chefitz

Founder/CEO

Allen B Chefitz, MD

Surgeon/Scientist

Ellie Long

Chief Operating Officer

Elisa Long, MD

MS in Computer Science, MIT

Rohingya Singh

Scientific Advisor

Rohit Singh, PhD

Research Scientist at MIT and Expert in Machine Learning and Genomics

Pyongwu Yang

Consultant

Pyongwu Yang, PhD

Physical Chemistry, MIT, Optical Engineering

Patents

US Patent No. 11,872,708 “Monitoring and Maintaining an Intravenous Assembly Without Medical Staff Involvement For Safe Distancing Enforcement” Jan 16 2024

U.S. Patent No. 11,452,454 “Self Administered Non-Invasive Transcutaneous Viral Detector” Sept 27, 2022

U.S. Patent No. 11,304,605 “Self Administered Non-Invasive Transcutaneous Viral Detector” April 19, 2022

U.S. Patent No. 11,291,408 “Eyewear System For Detecting And Indicating Presence Of Coronavirus” April 5, 2022

U.S. Patent No. 10,906,180 “Monitoring And Maintaining An Intravenous Assembly Without Medical Staff involvement For Safe Distancing Enforcement” Feb. 2, 2021

Along with several Continuation Patents, Foreign Applications and Pending Patents.

US Patents

Contact Us

Scroll to Top